NurExone Biologic Inc. (TSXV: NRX)
Health Care · Biotechnology · CA
CA$0.60
-3.33% today · -23.1% 1Y
NurExone Biologic Inc. (TSXV: NRX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $40.89M.
Over the last twelve months the share price has lost 23.1%, trading between 0.44 and 0.89.
Tweenvest scores NurExone Biologic Inc. across four factors: quality 35/100, value 35/100. Its strongest factor is quality.
NRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $40.89M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 0.33
- 52-week high
- CA$0.89
- 52-week low
- CA$0.44
- Avg volume (3M)
- —
- Shares outstanding
- 96.40M
- Employees
- —
- Next earnings
- —
About NurExone Biologic Inc.
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
- ISIN
- CA67059R1091
- Founded
- 2020
- Listed since
- Sep 13, 2022
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dogwood Therapeutics, Inc.NasdaqCM: DWTX | $41.47M | $1.22 | -12.86% |
| Biomolecular Life Holdings, Inc.OTCPK: BIOM | $41.44M | $0.81 | -18.18% |
| KoBioLabs, IncKOSDAQ: A348150 | $40.93M | ₩2,810.00 | -2.43% |
| Cutia TherapeuticsSEHK: 2487 | $40.89M | HK$0.86 | +0.58% |
| INmune Bio Inc.NasdaqCM: INMB | $40.52M | $1.46 | -4.58% |
| TegoScience Inc.KOSDAQ: A191420 | $40.24M | ₩6,700.00 | -5.63% |
| Instil Bio, Inc.NasdaqCM: TIL | $40.08M | $5.91 | -12.31% |
| Genomics BioSci & Tech. Co.,Ltd.TWSE: 4195 | $38.71M | NT$15.70 | -3.68% |
Figures last refreshed Oct 18, 2026.